The reported statements, read against the company's own industry.
Financials view
Market Capitalization
18.26BCNY
2.72B · vs all stocks (USD)
Updated Aug 20, 2026
Revenue (TTM)
46.52BCNY
6.92B · vs all stocks (USD)
Updated Aug 20, 2026
Profit Margin
-3.48%
vs Conglomerates peers
Updated Aug 20, 2026
Beta
0.7510x
vs all stocks
Updated Aug 20, 2026
52-Week Change
20.05%
vs all stocks
Updated Aug 20, 2026
Market Capitalization
18.26BCNY
2.72B · vs all stocks (USD)
Updated Aug 20, 2026
Enterprise Value
43.07BCNY
6.40B · vs all stocks (USD)
Updated Aug 20, 2026
Forward P/E
15.38x
vs Conglomerates peers
Updated Aug 20, 2026
Price to Sales (TTM)
0.4034x
vs Conglomerates peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 0.39×.Updated Aug 20, 2026
Price to Book (MRQ)
1.84x
vs Conglomerates peers
Updated Aug 20, 2026
Enterprise to Revenue
0.9260x
vs Conglomerates peers
Updated Aug 20, 2026
Enterprise to EBITDA
24.89x
vs Conglomerates peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 33.96×.Updated Aug 20, 2026
Gross Margin
7.63%
vs Conglomerates peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 4.17%.Updated Aug 20, 2026
Profit Margin
-3.48%
vs Conglomerates peers
Updated Aug 20, 2026
Operating Margin
0.82%
vs Conglomerates peers
Updated Aug 20, 2026
Return on Assets (TTM)
-0.81%
vs Conglomerates peers
Updated Aug 20, 2026
Return on Equity (TTM)
-10.69%
vs Conglomerates peers
Updated Aug 20, 2026
Revenue (TTM)
46.52BCNY
6.92B · vs all stocks (USD)
Updated Aug 20, 2026
Revenue per Share (TTM)
13.03CNYUpdated Aug 20, 2026
Quarterly Revenue Growth
-13.20%
vs Conglomerates peers
Updated Aug 20, 2026
Gross Profit (TTM)
1.94BCNY
288.76M · vs all stocks (USD)
Updated Aug 20, 2026
EBITDA (TTM)
1.27BCNY
188.60M · vs all stocks (USD)
Updated Aug 20, 2026
Net Income (TTM)
-1.62BCNY
-240.66M · vs all stocks (USD)
Updated Aug 20, 2026
Quarterly Earnings Growth (YoY)
28.08%
vs Conglomerates peers
Updated Aug 20, 2026
Operating Cash Flow (TTM)
2.60BCNY
386.21M · vs all stocks (USD)
Updated Aug 20, 2026
Levered Free Cash Flow (TTM)
1.28BCNY
190.10M · vs all stocks (USD)
Updated Aug 20, 2026
5-Year Average Dividend Yield
2.10%
vs all stocks
Updated Aug 20, 2026
Payout Ratio
0.00%
vs Conglomerates peers
Updated Aug 20, 2026
Minority Interest (Equity)
5.36BCNYFY2025 · Dec 31, 2025
Revenue
47.34BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
45.71BCNYFY2025 · Dec 31, 2025
Gross Profit
1.63BCNYFY2025 · Dec 31, 2025
Operating Income
-932.88MCNY
-138.73M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-2.42BCNYFY2025 · Dec 31, 2025
Income Tax Expense
3.97MCNYFY2025 · Dec 31, 2025
Net Income
-2.43BCNYFY2025 · Dec 31, 2025
EBIT
-1.79BCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
1.27BCNYFY2025 · Dec 31, 2025
Research & Development
628.93MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
501.22MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
144.69MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
73.20MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
635.38MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.6200CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.6200CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
3.59BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
3.59BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-2.43BCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
203.81MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-2.19BCNYFY2025 · Dec 31, 2025
Free Cash Flow
-3.73BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
4.20BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-2.43BCNYFY2025 · Dec 31, 2025
Other Non-cash Items
702.92MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-387.42MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-77.58MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-1.54BCNYFY2025 · Dec 31, 2025
Net Acquisitions
265.09MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-124.60MCNYFY2025 · Dec 31, 2025
Sale of Investments
112.60MCNYFY2025 · Dec 31, 2025
Other Investing Activity
49.50MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-1.23BCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
16.81BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-15.17BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-692.25MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-167.63MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
778.07MCNYFY2025 · Dec 31, 2025
Shares Outstanding
3.59BSharesUpdated Aug 20, 2026
Float Shares
1.58BSharesUpdated Aug 20, 2026
% Held by Insiders
59.14%
vs all stocks
Updated Aug 20, 2026
% Held by Institutions
3.52%
vs all stocks
Updated Aug 20, 2026
Total Cash (MRQ)
5.42BCNY
805.71M · vs all stocks (USD)
Updated Aug 20, 2026
Total Cash per Share (MRQ)
1.51CNYUpdated Aug 20, 2026
Total Debt (MRQ)
24.43BCNY
3.63B · vs all stocks (USD)
Updated Aug 20, 2026
Total Debt to Equity (MRQ)
1.58x
vs Conglomerates peers
Updated Aug 20, 2026
Current Ratio (MRQ)
1.24x
vs Conglomerates peers
Updated Aug 20, 2026
Book Value per Share (MRQ)
2.84CNYUpdated Aug 20, 2026
Total Assets
50.15BCNY
7.46B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
15.45BCNYFY2025 · Dec 31, 2025
Total Liabilities
34.28BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
34.70BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
22.38BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
11.89BCNYFY2025 · Dec 31, 2025
Cash
797.47MCNYFY2025 · Dec 31, 2025
Cash Equivalents
3.50BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
4.30BCNYFY2025 · Dec 31, 2025
Other Short-term Investments
400.00KCNYFY2025 · Dec 31, 2025
Accounts Receivable
2.48BCNYFY2025 · Dec 31, 2025
Inventory
3.50BCNYFY2025 · Dec 31, 2025
Accounts Payable
7.26BCNYFY2025 · Dec 31, 2025
Short-term Debt
2.65BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
94.14MCNYFY2025 · Dec 31, 2025
Long-term Debt
21.74BCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
209.28MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
3.59BCNYFY2025 · Dec 31, 2025
Retained Earnings
569.19MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
15.87BCNY
2.36B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
633.49KCNYFY2025 · Dec 31, 2025
52-Week Low
3.75CNYUpdated Aug 20, 2026
52-Week High
9.85CNYUpdated Aug 20, 2026
52-Week Change
20.05%
vs all stocks
Updated Aug 20, 2026
Beta
0.7510x
vs all stocks
Updated Aug 20, 2026
50-Day MA
6.31CNYUpdated Aug 20, 2026
200-Day MA
4.96CNYUpdated Aug 20, 2026
Avg 10-Day Volume
155.91MSharesUpdated Aug 20, 2026
Avg 30-Day Volume
113.34MSharesUpdated Aug 20, 2026
Diluted EPS (TTM)
-0.4500CNYUpdated Aug 20, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.25: grey zoneSignificant
Altman Z-Score: 1.25
Supply Chain
Upstream position: supplies 8 industries, depends on 0Notable
Outgoing: 8.00Incoming: 0.00
Scale
Market cap is $2.72B, above the global median of $1.15BNotable
Market cap (USD): 2,716,110,684.284Global Median: 1,146,734,693.424
Revenue is $6.92B, above the global median of $520.53MNotable